The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib/II study of second-line therapy with panitumumab, irinotecan and everolimus (PIE) in metastatic colorectal cancer (mCRC) with KRAS wild type (WT): Biomarker substudy.
 
Amanda Rose Townsend
Research Funding - Amgen (Inst)
 
Jennifer Hardingham
No Relationships to Disclose
 
Niall C. Tebbutt
Consulting or Advisory Role - Amgen (Inst)
Research Funding - Amgen (Inst); Novartis (Inst)
 
Christos Stelios Karapetis
Consulting or Advisory Role - Amgen (Inst)
 
Nimit Singhal
No Relationships to Disclose
 
Rohit Joshi
No Relationships to Disclose
 
Sue Yeend
No Relationships to Disclose
 
Pamela Cooper
No Relationships to Disclose
 
Hilary Dorward
No Relationships to Disclose
 
Timothy Jay Price
Consulting or Advisory Role - Amgen (Inst); Merck Serono (Inst); Roche (Inst)